|
|
Article: Researchers from University of Manchester discuss findings in cancer vaccines.
- Article from:
- Cancer Vaccine Week
- Article date:
- November 16, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
New investigation results, 'A survey of adolescent experiences of human papillomavirus vaccination in the Manchester study,' are detailed in a study published in British Journal of Cancer. "There is little information on girls' experiences of human papillomavirus (HPV) vaccination in the prevention of cervical cancer. We investigated the views of adolescent girls who had been offered the vaccine as part of a feasibility study conducted in Manchester," investigators in Manchester, the United Kingdom report (see also Cancer Vaccines).
"All 12 to 13-year-old girls in two primary care trusts were offered three doses of Cervarix (manufactured by GlaxoSmithKline). A ...